Download Scientific Programme

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Poster Session 42
Surgical treatment of renal tumours
Poster Session 42
Sunday, 13 March
14:00 - 15:30
Location:
Room Milan (Hall B2, level 0)
Chairs:
A. Bex, Amsterdam (NL)
B. Peyronnet, Rennes (FR)
Aims and objectives of this presentation
To review the latest releases on patients submitted to nephrectomy for the treatment of renal
tumours, including outcomes, surgical tricks and predictive factors of renal functioning after
nephrectomy.
Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations
are 2 minutes in length, followed by 2 minutes for discussion. Extended presentations (*) are
3 minutes in length, followed by 3 minutes for discussion.
520
Perioperative 30-day mortality rates are dependent on hospital surgical volume - results from a
Norwegian population based study on surgical treatment for renal cell carcinoma
By: Hjelle K.1, Johannesen T.2, Beisland C.1
Institutes:1Haukeland University Hospital, Dept. of Urology, Bergen, Norway, 2Cancer Registry of
Norway, Oslo, Norway
521
Impact of surgical volume on perioperative outcomes after nephrectomy with tumor
thrombectomy
By: Linares Espinós E.1, Martinez-Salamanca J.I.2, Carballido J.2, Gonzalez J.3, Capitanio U.4,
Chantada V.5, Chromecki T.6, Ciancio G.7, Daneshmand S.8, Evans C.P.9, Gontero P.10, Haferkamp
A.11, Hohenfellner M.12, Huang W.13, Koppie T.M.14, Lorentz A.15, Master V.15, McKiernan J.16,
Montorsi F.4, O'Malley P.17, Pahernik S.12, Palou J.18, Pontones J.L.19, Pruthi R.20, Rodriguez Faba
O.18, Russo P.21, Scherr D.S.17, Spahn M.22, Terrone C.23, Tilki D.9, Vázquez-Martul, D.5, Vera Donoso
C.19, Vergho D.22, Wallen E.20, Zigeuner R.6, Libertino J.24
Institutes:1Hospital Universitario Infanta Sofia, Dept. of Urology, Madrid, Spain, 2Hospital
Universitario Puerta De Hierro-Majadahonda, Dept. of Urology, Madrid, Spain, 3Hospital Central De
La Cruz Roja San José Y Santa Adela, Dept. of Urology, Madrid, Spain, 4Hospital San Raffaele,
University Vita-Salute, Dept. of Urology, Milan, Italy, 5Complejo Hospitalario Universitario A
Coruña, Dept. of Urology, Coruña, Spain, 6Medical University of Graz, Dept. of Urology, Graz,
Austria, 7Miami Transplant Institute, University of Miami, Dept. of Urology, Miami, United States of
America, 8USC/Norris Comprehensive Cancer Center, Dept. of Urology, Los Angeles, United States
of America, 9UC Davis Medical Center, Dept. of Urology, Sacramento, United States of America, 10
A.O.U. San Giovanni Battista, University of Turin, Dept. of Urology, Turin, Italy, 11University of
Frankfurt, Dept. of Urology, Frankfurt, Germany, 12University of Heidelberg, Dept. of Urology,
Heidelberg, Germany, 13New York University School of Medicine, Dept. of Urology, New York,
United States of America, 14Oregon Health & Science University, Dept. of Urology, Portland, United
States of America, 15Emory University, Dept. of Urology, Atlanta, United States of America, 16
Columbia University, Dept. of Urology, New York, United States of America, 17Weill Cornell Medical
Center, Dept. of Urology, New York, United States of America, 18Fundación Puigvert, Dept. of
Urology, Barcelona, Spain, 19Hospital Universitario Y Politécnico La Fe, Dept. of Urology, Valencia,
Spain, 20UNC At Chappel Hill, Dept. of Urology, Chappel Hill, United States of America, 21Memorial
Sloan Kettering Cancer Center, Dept. of Urology, New York, United States of America, 22University
of Würzburg, Dept. of Urology, Würzburg, Germany, 23Maggiore Della Carita Hospital, University of
Eastern Piedmont, Dept. of Urology, Novara, Italy, 24Lahey Clinic, Dept. of Urology, Burlington,
United States of America
522
Temporal trends in the rate of lymph node dissection for renal cell carcinoma
Scientific Programme
EAU Munich 2016
1
Poster Session 42
By: Capitanio U.1, Stewart G.2, Klatte T.3, Volpe A.4, Akdogan B.5, Roscigno M.6, Langenhuijsen H.7,
Marszalek M.8, Rodriguez Faba O.9, Salagierski M.10, Minervini A.11, Brookman-May S.12
Institutes:1IRCCS Ospedale San Raffaele, Dept. of Urology, Milan, Italy, 2Western General Hospital,
Dept. of Urology, Edinburgh, United Kingdom, 3Vienna Medical University, Dept. of Urology, Vienna,
Austria, 4Maggiore Della Carità Hospital, Dept. of Urology, Novara, Italy, 5Hacettepe University,
Dept. of Urology, Ankara, Turkey, 6Papa Giovanni XXIII Hospital, Dept. of Urology, Bergamo, Italy, 7
Radboud University Medical Center, Dept. of Urology, Nijmegen, The Netherlands, 8Donauspital,
Dept. of Urology, Vienna, Austria, 9Fundacio-Puigvert, Dept. of Urology, Barcelona, Spain, 10Kent &
Canterbury Hospital, Dept. of Urology, Canterbury, United Kingdom, 11Azienda Ospedaliero
Universitaria Careggi, Dept. of Urology, Florence, Italy, 12LMU-Klinikum der Universität München,
Dept. of Urology, Munich, Germany
523
Impact of lymph node dissection at the time of radical nephrectomy and tumour thrombectomy on
oncological outcomes of patients with renal cell carcinoma and tumour thrombus
By: Tilki D.2, Terrone C.1, Chandrasekar T.2, Ciancio G.3, Daneshmand S.4, Martinez-Salamanca J.5,
Montorsi F.6, Rodriguez-Faba O.7, Zigeuner R.8, Libertino J.9, Evans C.2
Institutes:1Maggiore Della Carita Hospital, University of Eastern Piedmont, Division of Urology,
Novara, Italy, 2University of California, Davis, School of Medicine, Dept. of Urology, Sacramento,
United States of America, 3University of Miami, Miami Transplant Institute, Miami, United States of
America, 4USC/Norris Comprehensive Cancer Center, Dept. of Urology, Los Angeles, United States
of America, 5Hospital Universitario Puerta De Hierro-Majadahonda, Universidad Autónoma De
Madrid, Dept. of Urology, Madrid, Spain, 6Hospital San Raffaele, University Vita-Salute, Dept. of
Urology, Milan, Italy, 7Fundació Puigvert, Dept. of Urology, Barcelona, Spain, 8Medical University of
Graz, Dept. of Urology, Graz, Austria, 9Lahey Clinic, Dept. of Urology, Burlington, United States of
America
524
Preoperative renal artery embolization in renal carcinoma with venous thrombus: Preliminary
results of a multicenter study
By: Vazquez-Martul Pazos D.1, Chantada V.C.1, Capitanio U.2, Carballido J.A.3, Chromecki T.4,
Ciancio G.5, Daneshmand S.6, Evans C.P.7, Gontero P.8, González J.9, Haferkamp A.10, Hohenfellner
M.11, Huang W.C.12, Koppie T.M.13, Linares Espinós E.14, Lorentz A.15, Martínez-Salamanca J.I.3,
Mass A.Y.12, Master V.A.15, McKiernan J.M.16, Montorsi F.2, O'Malley P.17, Pahernik S.11, Palou J.18,
Pontones Moreno J.L.19, Pruthi R.S.20, Rodriguez Faba O.18, Russo P.21, Scherr D.S.17, Shariat S.F.22,
Spahn M.23, Terrone C.24, Tilki D.7, Vera Donoso C.D.19, Vergho D.23, Wallen E.M.20, Zigeuner R.4,
Libertino J.A.25
Institutes:1Complejo Hospitalario Universitario A Coruña, Dept. of Urology, A Coruña, Spain, 2
Hospital San Raffaele, University Vita-Salute, Dept. of Urology, Milan, Italy, 3Hospital Universitario
Puerta de Hierro-Majadahonda, Universidad Autónoma de Madrid, Dept. of Urology, Madrid, Spain,
4
Medical University of Graz, Dept. of Urology, Graz, Austria, 5Miami Transplant Institute, University
of Miami, Dept. of Urology, Miami, United States of America, 6USC/Norris Comprehensive Cancer
Center, Dept. of Urology, Los Angeles, United States of America, 7UC Davis Medical Center, Dept. of
Urology, Sacramento, United States of America, 8A.O.U. San Giovanni Battista, University of Turin,
Dept. of Urology, Turin, Italy, 9Hospital Central de la Cruz Roja San José y Santa Adela, Dept. of
Urology, Madrid, Spain, 10University of Frankfurt, Dept. of Urology, Frankfurt, Germany, 11University
of Heidelberg, Dept. of Urology, Heidelberg, Germany, 12New York University School of Medicine,
Dept. of Urology, New York, United States of America, 13Oregon Health & Science University, Dept.
of Urology, Portland, United States of America, 14Hospital Universitario Infanta Sofía, Dept. of
Urology, Madrid, Spain, 15Emory University, Dept. of Urology, Atlanta, United States of America, 16
Columbia University College of Physicians and Surgeons, Dept. of Urology, New York, United
States of America, 17Weill Cornell Medical Center, Dept. of Urology, New York, United States of
America, 18Fundació Puigvert, Dept. of Urology, Barcelona, Spain, 19Hospital Universitario y
Politécnico La Fe, Dept. of Urology, Valencia, Spain, 20UNC at Chapel Hill, Dept. of Urology, Chapel
Hill, United States of America, 21Memorial Sloan Kettering Cancer Center, Dept. of Surgery, Urology
Service, New York, United States of America, 22Medical University of Vienna, Dept. of Urology,
Vienna, Austria, 23University of Würzburg, Dept. of Urology, Würzburg, Germany, 24Maggiore della
Carita Hospital, University of Eastern Piedmont, Division of Urology, Novara, Italy, 25Lahey Clinic,
Dept. of Urology, Burlington, United States of America
*525
Control of the renal artery after removal of tumor thrombus from the inferior vena cava: Analysis
Scientific Programme
EAU Munich 2016
2
Poster Session 42
of the efficacy and safety of a new surgical approach
By: Lesovoy V., Shchukin D., Garagatiy I., Khareba G., Polyakov M.
Institutes:Kharkiv National Medical University, Dept. of Urology, Nephrology and Andrology,
Kharkiv, Ukraine
*526
Robotic radical nephrectomy with inferior vena cava tumor thrombectomy: Initial series
By: Simone G.1, Ferriero M.1, Papalia R.2, Abreu A.L.3, Guaglianone S.1, Minisola F.1, Tuderti G.1,
Misuraca L.1, Pompeo V.1, Mastroianni R.2, Aron M.3, Desai M.3, Gill I.S.3, Gallucci M.1
Institutes:1"Regina Elena" National Cancer Institute, Dept. of Urology, Rome, Italy, 2Campus
Biomedico University of Rome, Dept. of Urology, Rome, Italy, 3USC Institute of Urology and
Departments of Urology, Keck School of Medicine, University of Southern, Dept. of Urology, Los
Angeles, United States of America
*527
Incidence of cardiovascular events after tumour nephrectomy in young patients – a single center,
matched pair analysis between donor nephrectomy and radical tumour nephrectomy comprising a
long term follow-up
By: Levien P., Nestler S., Jäger W., Neisius A., Thomas C., Kamal M.M., Hampel C., Thüroff J., Roos
F.C.
Institutes:Medical Center, University of Mainz, Mainz, Germany
*528
Tumour size is associated with compensatory hypertrophy in the contra-lateral kidney after
radical nephrectomy in patients with renal cell carcinoma
By: Park B.H.1, Kim J.I.2, Jeong B.C.3, Seo S.I.3, Jeon S.S.3, Lee H.M.3, Choi H.Y.3, Jeon H.G.3
Institutes:1Uijeongbu St. Mary’s Hospital, Dept. of Urology, Uijeongbu-Si, South Korea, 2Kyung Hee
University Hospital At Gangdong, Dept. of Radiology, Seoul, South Korea, 3Samsung Medical
Center, Dept. of Urology, Seoul, South Korea
*529
Longitudinal changes in renal function after radical nephrectomy and risk factors for
postoperative severe renal impairment: A Japanese multicenter study using a linear mixed model
analysis
By: Yokoyama M.1, Kawamura N.1, Fujii Y.1, Inoue M.1, Ishioka J.1, Numao N.1, Matsuoka Y.1, Saito
K.1, Arisawa C.2, Okuno T.3, Noro A.4, Morimoto S.5, Kihara K.1
Institutes:1Tokyo Medical and Dental University Graduate School, Dept. of Urology, Tokyo, Japan,
2
Tobu Chiiki Hospital, Dept. of Urology, Tokyo, Japan, 3JA Toride Medical Center, Dept. of Urology,
Toride, Japan, 4Saitama Red Cross Hospital, Dept. of Urology, Saitama, Japan, 5Tsuchiura Kyodo
General Hospital, Dept. of Urology, Tsuchiura, Japan
*530
The effect of time elapsed from surgery on the subsequent risk of cancer specific mortality in
renal cell carcinoma patients
By: Dell'Oglio P.1, Larcher A.1, Capogrosso P.1, Nini A.1, La Croce G.1, Stabile A.1, Di Trapani E.1,
Karakiewicz P.2, Briganti A.1, Montorsi F.1, Capitanio U.1, Bertini R.1
Institutes:1IRCCS Ospedale San Raffaele, Dept. of Urology, Milan, Italy, 2Cancer Prognostics and
Health Outcomes Unit, University of Montreal Health Center, Dept. of Urology, Montreal, Canada
*531
How did we obtain complete remission with patients who have metastatic renal cancer using
targeted therapies?
By: Brecheteau F., Carrouget J., Lebdai S., Azzouzi A.R., Bigot P.
Institutes:Angers University Hospital, Dept. of Urology, Angers, France
*532
Metastatic renal cell carcinoma with cytoreductive nephrectomy. Risk model of cancer-specific
survival
By: Velis Campillo J.M., Ancizu Marckert F.J., Hevia Suárez M., Merino Narro I., García Cortés A.,
Tienza Fernández A., Algarra Navarro R., Pascual Piédrola I., Robles García J.E.
Institutes:Clínica Universidad de Navarra, Dept. of Urology, Pamplona, Spain
Scientific Programme
Powered by TCPDF (www.tcpdf.org)
EAU Munich 2016
3